ConductScience.org, home

Trial · NCT01503775

Registered outcomes13

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primary
The long term safety of the coiling procedure with the CODMAN TRUFILL®'s line of coils will be assessed by the combined morbidity-mortality rate (CMMR) observed during the procedure and up to 1 year post-procedure follow-up.
Observed during the procedure and up to 1 year post-procedure follow-up
SecondaryThe procedural CMMR observed during the procedure and up to 30 Days post procedure follow-up.Observed during the procedure and up to 30 Days post procedure follow-up.
SecondaryThe rate of permanent morbidity and mortality observed at 30 Days and at 1 year post-procedure follow-up, defined as a mRS of 3 to 6.Observed at 30 Days and at 1 year post-procedure follow-up
SecondaryThe rate of absence of deterioration or improvement of the neurological status observed at 30 days and at 1 year post procedure follow-upObserved at 30 days and at 1 year post procedure follow-up
SecondaryThe overall rate of Adverse Event/Serious Adverse Event observed during the procedure, at 30 days and up to 1 year post-procedure follow-upObserved during the procedure, at 30 days and up to 1 year post-procedure follow-up
SecondaryThe rate of Adverse Event/Serious Adverse Event related to the device and/or to the procedure observed during the procedure, at 30 days and up to 1 year post-procedure follow-upObserved during the procedure, at 30 days and up to 1 year post-procedure follow-up
SecondaryThe rate of Unanticipated Adverse Device Effects observed during the procedure, at 30 days and up to 1 year post-procedure follow-upObserved during the procedure, at 30 days and up to 1 year post-procedure follow-up
SecondaryThe rate of per-procedural subarachnoid hemorrhage of the treated aneurysm and rate of per-procedural SAH leading to a modification of the procedure initially plannedDuring the procedure
SecondaryThe rate of recurrent subarachnoid hemorrhage of the treated aneurysm at one-year post-procedure follow-up1 year post-procedure
SecondaryThe rate of aneurysm occlusion at the end of the procedure and at 1 year post-procedure follow-upEnd of the procedure and at 1 year post-procedure follow-up
Secondary
The rate of aneurysm recanalisation up to 1 year post-treatment defined as any increase in the size of the remnant or defined as a change of classification of the Raymond scale result related up to the 1 year post-procedure follow-up
Up to 1 year post-treatment
Secondary
The rate of spontaneous aneurysm regression up to 1 year post-treatment defined as any decrease in the size of the remnant or defined as a change of classification of the Raymond scale result related up to the 1 year post-procedure follow-up
Up to the 1 year post-procedure follow-up
SecondaryThe rate of retreatment at 1 year follow-up representing the rate of major recurrence on the target aneurysm observed up to the 1 year post-procedure follow-upUp to the 1 year post-procedure follow-up

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01503775/registered